Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 36.29 and traded as low as GBX 32. Cambridge Cognition shares last traded at GBX 34, with a volume of 15,321 shares traded.
Cambridge Cognition Stock Performance
The company’s 50-day moving average price is GBX 33.68 and its 200 day moving average price is GBX 36.27. The stock has a market capitalization of £18.31 million, a PE ratio of -8.70 and a beta of 0.81. The company has a debt-to-equity ratio of 29.16, a quick ratio of 0.96 and a current ratio of 0.40.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
